Stock ALQGC QUANTUM GENOMICS
Add to a list
To use this feature you must be a member
Log inSign up

Financials Quantum Genomics

Equities

ALQGC

FR0011648971

Biotechnology & Medical Research

Market Closed - Euronext Paris
Other stock markets
 11:25:15 2024-04-26 am EDT 		5-day change 1st Jan Change
0.1292 EUR +1.89% Intraday chart for Quantum Genomics +9.86% +21.89%
Mar. 13 Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2024
Capitalization 1 59.3 130.7 117.2 4.085 4.503
Enterprise Value (EV) 1 48.14 103.6 106.7 -6.316 -4.197
P/E ratio -6.73 x -11.3 x -7.1 x -0.16 x -1.44 x
Yield - - - - -
Capitalization / Revenue 164 x 57.8 x 37.1 x 1.35 x -
EV / Revenue 133 x 45.8 x 33.7 x -2.09 x -
EV / EBITDA -4.48 x -7.48 x -5.64 x 0.21 x 1.68 x
EV / FCF -4.5 x - -6.31 x - 1.35 x
FCF Yield -22.2% - -15.8% - 73.9%
Price to Book 6 x - 10.3 x - 0.42 x
Nbr of stocks (in thousands) 17,545 26,673 27,348 34,620 34,855
Reference price 2 3.380 4.900 4.286 0.1180 0.1292
Announcement Date 3/26/20 3/25/21 4/28/22 5/26/23 -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2024
Net sales 1 0.3611 2.262 3.162 3.019 -
EBITDA 1 -10.75 -13.85 -18.9 -29.82 -2.5
EBIT 1 -10.76 -13.86 -19.19 -30.08 -2.9
Operating Margin -2,979.78% -612.77% -606.72% -996.57% -
Earnings before Tax (EBT) -10.63 -13.68 -19.22 -27.48 -
Net income 1 -9.078 -11.54 -16.56 -24.94 -3.1
Net margin -2,514.1% -510.13% -523.52% -826.04% -
EPS 2 -0.5025 -0.4319 -0.6034 -0.7154 -0.0900
Free Cash Flow 1 -10.7 - -16.91 - -3.1
FCF margin -2,963.17% - -534.57% - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share 2 - - - - -
Announcement Date 3/26/20 3/25/21 4/28/22 5/26/23 -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2020 S2 2021 S1 2021 Q3 2021 Q4 2021 S2 2022 S1
Net sales 0.3773 1.884 2.712 0.4 - 0.4507 -
EBITDA - - - - - - -
EBIT -5.955 -7.902 - - - -11.96 -
Operating Margin -1,578.41% -419.41% - - - -2,654.56% -
Earnings before Tax (EBT) -5.941 -7.743 - - - -11.87 -
Net income -5.081 -6.456 - - - -10.38 -11.95
Net margin -1,346.7% -342.62% - - - -2,302.09% -
EPS 1 -0.2500 -0.1900 - -0.1900 -0.1900 -0.3700 -0.4000
Dividend per Share - - - - - - -
Announcement Date 10/1/20 3/25/21 - 10/13/22 4/28/22 4/28/22 10/13/22
1EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2024
Net Debt 1 - - - - -
Net Cash position 1 11.2 27.1 10.5 10.4 8.7
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 -10.7 - -16.9 - -3.1
ROE (net income / shareholders' equity) -82.4% -61.8% -85.9% -332% -28.7%
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share 2 0.5600 - 0.4200 - 0.3100
Cash Flow per Share 2 -0.5900 -0.4500 -0.6100 -0.5800 -0.0800
Capex 1 0.02 0.41 0.05 - 0.3
Capex / Sales 4.98% 18.17% 1.44% - -
Announcement Date 3/26/20 3/25/21 4/28/22 5/26/23 -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
0.1292 EUR
Average target price
0.1 EUR
Spread / Average Target
-22.60%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
QUANTUM GENOMICS Stock Quantum Genomics
+21.89% 4.81M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ALQGC Stock
  4. Financials Quantum Genomics